GE HealthCare Eyes Sofie Biosciences Acquisition to Expand Imaging Chemicals
GE HealthCare is considering a deal worth up to $1 billion for Sofie Biosciences, which makes radiopharmaceuticals used in cancer PET scans.
Already have an account? Sign in.